ERBB2 and breast cancer: Moreover, the lack of effect on metastatic incidence in the MMTV-neu mice suggests that TNJ would not increase risk if the primary tumor cells are spreading outside the breast, which would be important for breast cancer patients taking TNJ for other health benefits or continuing problems that preceded cancer.